GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects

Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.

"When considering glucagon-like peptide-1 (GLP-1) receptor agonists for weight management in patients with obesity, how do you weigh the benefits against potential side effects, especially in patients with comorbidities?”

That is a question Patient Care Online asked obesity medicine specialist Michael Crotty, MD, in a recent interview. In the video above, Dr Crotty discusses the benefits of GLP-1 receptor agonists in weight management and their impact on health. He also emphasizes the importance of treating obesity as a chronic disease with evidence-based treatments, from foundational lifestyle interventions and behavioral support to pharmacotherapy and surgery.

RELATED: Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications

Dr Crotty is also the co-founder and clinical lead of My Best Weight in Dublin, Ireland.